Provided By GlobeNewswire
Last update: Mar 31, 2025
PARIS and CAMBRIDGE, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2024, on Wednesday, April 2, 2025, after the close of the U.S. market.
Read more at globenewswire.comNASDAQ:NBTX (6/11/2025, 3:44:00 PM)
5.08
+0.23 (+4.74%)
Find more stocks in the Stock Screener